Telma LN 40 mg Tablet

Telma LN 40 mg Tablet

Prescription requiredRx Required

Salt Composition: Cilnidipine (10mg) + Telmisartan (40mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

15 Tablet

About The Product

Arb + Ccb Combination For Vascular Relaxation

Description

Telma LN 40mg tablet is a prescription based medication approved by healthcare professional. It is used to help manage high blood pressure (hypertension) in adults by relaxing blood vessels, allows blood to flow more easily and help reduce the risk of heart attack, stroke and kidney problems.

Its active ingredient is Clinidipine in 10mg concentration and Telmisartan in 40mg concentration that belongs to the drug class in a combination of Angiotensin II receptor blocker (ARB) and Calcium channel blocker.

Doctor recommend this medicine as a first line therapy to manage the disease well. Do not self administer the medication without consultation with a healthcare professional.

Uses

Manage high blood pressure


Side Effects

Always follow doctor prescription as Telma LN tablet cause various side effects based on the patient overall health condition and response to the treatment.

Common symptoms include:

  • Tiredness
  • Feeling sleepy
  • Headaches
  • Back pain
  • Difficulty in breathing
  • Stomach upset
  • Nausea
  • Muscle pain
  • Swelling of ankles and feet
  • Dizziness
  • vision change
  • palpitation
  • Fever
  • Increased potassium level

How To Use

  • Telma LN 40mg tablet dosage and duration is correctly administered by the healthcare professional.
  • The medicine should be taken orally with a whole glass of water.
  • Do not crush, chew or break the tablet as it may affect the way the medicine works in the body.
  • Never self administer the medication as improper use can lead to serious side effects and complications.


How It Works

  • Telma LN 40mg tablet is first line therapy with two active drugs Telmisartan that blocks angiotensin II, a hormone that narrows blood vessels.
  • While Clinidipine blocks calcium movement into the smooth muscle of blood vessels, causing them to relax and widen.
  • They both work together to lower blood pressure, reduce the heart's workload and help protect viral organs like the heart, brain and kidney from damaged caused by uncontrolled hypertension.

Safety Advice

Alcohol
Alcohol can worsen the side effects like low blood pressure and dizziness. Try to limit or avoid intake of alcohol while using Telma LN 40mg tablet
Pregnancy
Telma LN 40mg tablet is not recommended to the pregnant women as it causes serious to the unborn baby.
Breast Feeding
Telma LN 40mg tablet should be used with caution or avoided during breastfeeding. Seek medical advice if any symptoms occur to the mother or baby.
Driving
Telma LN 40mg may cause dizziness and drowsiness in some patients. Avoid driving and operate heavy machinery if the symptoms persist or worsen.
Kidney
Inform your doctor before taking Telma LN 40mg tablet, as it may affect kidney function and could lead to complications or worsening of existing conditions.
Liver
Telma LN 40mg tablet should not be taken by liver patients as it can disrupt the overall treatment.

FAQs

Take Telma LN 40mg tablet once daily as prescribed by the doctor.

It should be taken with or without food at the same time everyday to enhance the effectiveness of the treatment.

References

  • Chandra, K. S., & Ramesh, G. (2013). The fourth-generation Calcium channel blocker: cilnidipine. Indian heart journal, 65(6), 691-695.
  • Takahara, A. (2009). Cilnidipine: a new generation Ca2+ channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovascular therapeutics, 27(2), 124-139.
  • Shete, M. M. (2016). Cilnidipine: next generation calcium channel blocker. J Assoc Physicians India, 64(4), 95-99.
  • Deppe, S., Böger, R. H., Weiss, J., & Benndorf, R. A. (2010). Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties. Expert opinion on drug metabolism & toxicology, 6(7), 863-871.
  • Destro, M., Cagnoni, F., Dognini, G. P., Galimberti, V., Taietti, C., Cavalleri, C., & Galli, E. (2011). Telmisartan: just an antihypertensive agent? A literature review. Expert opinion on pharmacotherapy, 12(17), 2719-2735.​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026